-
September 22, 2021
Laurie Mims of Keker Van Nest & Peters LLP led a trial team that won former shareholders of FerroKin Biosciences more than $80 million in a post-merger dispute with Shire Pharmaceuticals, earning her a spot as one of Law360's 2021 Life Sciences MVPs.
-
September 21, 2021
Skadden Arps Slate Meagher & Flom LLP partner Jennifer Bragg was part of the legal team that negotiated Purdue Pharma's guilty plea with the U.S. Department of Justice over its illegal marketing of opioids and helped a testing lab beat a $178 million whistleblower suit, earning her a spot as one of Law360's 2021 Life Sciences MVPs.
-
September 20, 2021
Gibson Dunn & Crutcher LLP partner Jane Love, Ph.D., helped Novartis Pharmaceuticals Corp. beat a challenge to its blockbuster multiple sclerosis drug Gilenya in a Delaware federal court case, earning her a spot among Law360's 2021 Life Sciences MVPs.
-
September 17, 2021
Hannah H. England (Freeman) of Ropes & Gray LLP has advised on a number of complex transactions in the biopharma sector, including UniQure's licensing deal with CSL Behring over gene therapy for patients with hemophilia B, earning her a spot among Law360's 2021 Life Sciences MVPs.
-
August 30, 2021
The elite slate of attorneys chosen as Law360's 2021 MVPs have distinguished themselves from their peers by securing hard-earned successes in high-stakes litigation, complex global matters and record-breaking deals.
-
October 09, 2020
White & Case LLP's Robert Milne led Hospira Inc. to victory in high-stakes litigation over alleged collusion to artificially reduce the supply of IV saline and guided Pfizer out of a bellwether biosimilar antitrust class action, making him one of Law360's 2020 Life Sciences MVPs.
-
October 07, 2020
Matt Hurd of Sullivan & Cromwell LLP's life sciences practice guided several multibillion-dollar deals in the past year, including Bayer's sale of its animal health business and Novartis' merger with biopharmaceutical firm The Medicines Co., earning him a spot as one of Law360's 2020 Life Sciences MVPs.
-
October 08, 2020
Weil Gotshal & Manges LLP's Derek Walter has spent the past year helping Bio-Rad Laboratories defend patents before the Patent Trial and Appeal Board and in federal court — including helping the company win a Federal Circuit decision against 10X Genomics — earning him a spot as one of Law360's 2020 Life Sciences MVPs.
-
October 06, 2020
Latham & Watkins LLP's Daniel Brown and Ken Schuler represented specialty drug company Eagle Pharmaceuticals in several big wins and led Par Pharmaceutical to victory in an infringement suit over its Adrenalin patent, placing them among Law360's 2020 Life Sciences MVPs.
-
October 05, 2020
Covington & Burling LLP's Jennifer Plitsch has spent much of the past year advising companies like Moderna on how to help deal with the COVID-19 crisis, earning her a spot as one of Law360's 2020 Life Sciences MVPs.
-
October 04, 2020
The elite slate of attorneys chosen as Law360's 2020 MVPs have distinguished themselves from their peers by securing hard-earned successes in high-stakes litigation, complex global matters and record-breaking deals.
-
November 18, 2019
Cohen Milstein Sellers & Toll PLLC's Sharon K. Robertson has helped plaintiffs score big wins in antitrust cases accusing pharmaceutical companies of not playing by the rules, including a nearly $104.8 million settlement for Lidoderm end-payors in a suit alleging a pay-for-delay scheme, landing her among Law360's 2019 Life Sciences MVPs.
-
November 15, 2019
Steptoe & Johnson LLP partner John Molenda won a long-fought patent victory on behalf of Sanofi and Regeneron, while separately preparing to take Apotex to trial against both Pfizer and Celgene, earning him a spot among Law360's 2019 Life Sciences MVPs.
-
November 14, 2019
Gibson Dunn & Crutcher LLP partner Jane Love was able to convince the Federal Circuit to affirm a lower court's decision that upheld a patent on her client Novartis AG's multiple sclerosis drug Gilenya, a ruling that will prevent regulatory approval of a generic version, earning her a spot among Law360's 2019 Life Sciences MVPs.
-
November 13, 2019
Edward R. Reines, of Weil Gotshal & Manges LLP's life sciences practice, helped a major biotech company block its competitor from continuing to infringe a DNA manipulation method over the past year, earning him a place among Law360's 2019 Life Sciences MVPs.
-
November 12, 2019
Christopher P. Borello of Venable LLP's life sciences practice worked against GlaxoSmithKline to secure an $89.7 million inhaler patent infringement verdict for U.K.-based Vectura Ltd. and helped Nalpropion Pharmaceuticals uphold a weight loss medication patent, earning him a spot as one of Law360's 2019 Life Sciences MVPs.
-
November 08, 2019
The elite slate of attorneys chosen as Law360's 2019 MVPs have distinguished themselves from their peers by securing hard-earned successes in high-stakes litigation, complex global matters and record-breaking deals.
-
December 17, 2018
Matt Hurd of Sullivan & Cromwell LLP's life sciences practice shepherded Bayer through its record-breaking acquisition of Monsanto, worked on a merger that created a $1.75 billion generics pharmaceutical company and advised Amgen Inc. on a $10 billion stock offering, earning him a spot as one of Law360's 2018 Life Sciences MVPs.
-
December 14, 2018
Kirkland & Ellis LLP partner Jay Lefkowitz convinced the Fourth Circuit that a Maryland drug pricing law violates the dormant commerce clause and is therefore unconstitutional, earning him a spot as one of Law360's 2018 Life Sciences MVPs.
-
December 13, 2018
Adam Golden of Hogan Lovells has been involved in several high-profile life science deals over the last year — including the $9 billion acquisition of Juno Therapeutics by Celgene, one of the largest biotech companies in the country, and Novartis' $8.7 billion acquisition of AveXis Inc. — landing him a spot among Law360's 2018 Life Sciences MVPs.
-
December 12, 2018
Lori Cohen, co-chair of Greenberg Traurig's global litigation practice and chair of the firm's trial practice group, spearheaded big wins for life sciences clients in the past year, including the Seventh Circuit's rejection of state lawsuits in national litigation over eye drop doses, earning her a spot among Law360's 2018 Life Sciences MVPs.
-
December 11, 2018
The head of Fish & Richardson PC's life sciences litigation practice, Jonathan Singer, persuaded a federal judge to overturn a $2.5 billion patent infringement verdict against Gilead Sciences Inc., earning him a spot as one of Law360's 2018 Life Sciences MVPs.
-
November 21, 2018
The elite slate of attorneys chosen as Law360's 2018 MVPs have distinguished themselves from their peers by securing hard-earned successes in high-stakes litigation, complex global matters and record-breaking deals.
-
December 19, 2017
Fish & Richardson PC’s Dorothy Whelan notched a number of inter partes review victories earlier this year that invalidated key patents on AbbVie’s blockbuster autoimmune disease drug Humira, earning her a spot among Law360’s 2017 Life Sciences MVPs.
-
December 18, 2017
Gibson Dunn & Crutcher LLP partner Jane Love found herself dealing with Japanese law in a U.S. court this year, but that didn't stop her and her team from successfully defending a Novartis multiple sclerosis treatment from a multi-front attack by challengers seeking to invalidate the company's patent, earning her a spot among Law360's 2017 Life Sciences MVPs.